Beiträge

Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?

Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells

Wilms‘ tumor gene 1 immunotherapy in pelvic gynecological malignancies

Myeloid-derived suppressor cells in glioma

Dendritic cell-based immunotherapy in ovarian cancer

Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours